Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Amlodipine/rosuvastatin/telmisartan - Yuhan

Next Previous
X
Search
Drug Profile

Amlodipine/rosuvastatin/telmisartan - Yuhan

Alternative Names: Amlodipine/telmisartan/rosuvastatin; Rosuvastatin/amlodipine/telmisartan; Rosuvastatin/telmisartan/amlodipine; Telmisartan/amlodipine/rosuvastatin; Telmisartan/rosuvastatin/amlodipine; YH 22189; YH-1604; YHP 1604

Latest Information Update: 28 Sep 2020

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Yuhan
  • Class Antihyperlipidaemics; Antihypertensives; Benzimidazoles; Benzoates; Dihydropyridines; Fluorobenzenes; Ischaemic heart disorder therapies; Pyrimidines; Small molecules; Sulfonamides
  • Mechanism of Action ACE inhibitors; Angiotensin type 2 receptor antagonists; Calcium channel antagonists; Cytochrome P-450 enzyme system inhibitors; HMG-CoA reductase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Discontinued Hyperlipidaemia; Hypertension

Most Recent Events

  • 28 Sep 2020 Discontinued - Phase-III for Hyperlipidaemia in South Korea (PO) (Yuhan pipeline, September 2020)
  • 28 Sep 2020 Discontinued - Phase-III for Hypertension in South Korea (PO) (Yuhan pipeline, September 2020)
  • 21 Apr 2017 Yuhan initiates enrolment in a phase I trial in Healthy volunteers in South Korea (PO) (NCT03116516)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top